USPTO serial 99492717
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Hercules Pharmaceuticals, Inc.
Port Washington, NY, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Savannah Aronson, Esq.
27 Seaview BoulevardPort Washington, NY 11050United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | FDA-regulated pharmaceutical products, namely, brand medicine, generic medicine, biologics and biosimilars, orphan drugs, over-the-counter drugs, controlled substances, vitamins, and supplements for the treatment of cardiovascular diseases; neurological disorders; psychiatric and psychological conditions; infectious diseases, namely, viral, bacterial, and fungal infections; HIV and hepatitis; oncological diseases and malignancies; dermatological conditions; pulmonary and respiratory disorders; nephrological diseases; gastrointestinal and hepatic conditions; hematologic disorders; reproductive and fertility-related conditions; immunological and allergic conditions; endocrine and metabolic disorders, namely, diabetes; musculoskeletal and orthopedic conditions; ophthalmologic disorders; transplant-related conditions and post-operative complications; all for the management of pain and other chronic or acute medical conditions. | ACTIVE | — |
| 035 | Wholesale distributorship services featuring prescription and non-prescription pharmaceutical products, medical devices, and other FDA-regulated products for licensed pharmacies, hospitals, healthcare systems, and other institutional purchasers; wholesale ordering services in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers; wholesale services by direct solicitation by sales agents in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers; on-line wholesale store services featuring prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers. | ACTIVE | — |
| 041 | Providing educational services, namely, conducting information sessions in the nature of live presentations by educational speakers and training programs, directed to pharmacies and healthcare providers, in the field of pharmaceutical wholesaling and distribution best practices, patient safety, and medication adherence. | ACTIVE | — |
| 042 | Quality control of pharmaceutical wholesale distribution services of others. | ACTIVE | — |
| 044 | Providing health information to pharmacies and healthcare providers in the field of medication adherence, safe use of pharmaceuticals, and patient safety | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 1, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 18, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 18, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |